Yes, it can be used for chronic weight management in individuals without diabetes
For mild localised injection site reactions: Cold compress application apply a clean, cool (not ice-cold) compress to the affected area for 1015 minutes to reduce inflammation and discomfort Avoid rubbing or scratching the injection site, as this may exacerbate irritation Topical emollients regular application of fragrance-free moisturisers can soothe dry or irritated skin Oral antihistamines non-sedating antihistamines such as cetirizine or loratadine may help relieve itching if troublesome For more significant or generalised rashes: Topical corticosteroids mild-to-moderate potency topical steroids may be prescribed for inflammatory rashes
doi: 10.1007/s10787-019-00647-9 23
Pea-sized amount, thin layer
Red Flags in Before and After Photos Different lighting: Bathroom fluorescent light vs golden-hour window light can make anyone's skin look dramatically different regardless of what product was used Different camera distance or angle: Even a few inches closer creates apparent texture smoothing "Results in 1 week": Anyone showing dramatic wrinkle reversal in one week is using either injectable delivery, a film-forming agent for temporary tightening, or misleading photography No defined timeframe: Legitimate results specify exactly how many weeks of use are shown No single variable: If the person changed multiple products during the documented period, you cannot attribute results to GHK-Cu specifically Green Flags in Credible Documentation Identical lighting in both photos (same room, same time of day, same source) 3D imaging or VISIA documentation the gold standard used in clinical studies Specified timeline with consistent single-product use Progressive documentation (4-week, 8-week, 12-week) rather than a single dramatic comparison Honest acknowledgment that results vary and are gradual The clinical studies that produced GHK-Cu's most impressive numbers 55.8% wrinkle volume reduction used VISIA 3D profilometry imaging systems that eliminate all lighting and angle variables entirely
A common protocol, for example, is to begin with about 20 mg of NAD+ administered subcutaneously and gradually increase the dose over subsequent injections up to around 100 mg per injection
